Company Update
Kestra Medical Technologies stock breaks $30 ceiling, hits new all‑time high
Kestra (KMTS) surged above $30, reaching a new all‑time high after repeatedly being rejected at that level. The company, valued at about $1.8 billion, reported a 60% revenue jump to $31 million and raised its full‑year forecast to $141 million, though it remains unprofitable with a $44.1 million net loss. Analysts note the breakout could target around $40, roughly 30% above the current price.